PATENT CLAIM ANALYSIS

Application Number: 15774575
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "450000"]

Abstract:
In various embodiments deformable nano-scale vehicles (DNV) are provided that are useful for the delivery of therapeutic agents. In certain embodiments the DNVs are capable of transdermal delivery and can additionally cross the blood-brain barrier.

Claim (Index 54):
The nanoscale drug delivery vehicle of  claim 53 , wherein said DNV contains an agent selected from the group consisting of APP or eAPP, galangin, disulfiram and/or analogues thereof, honokiol and/or analogues thereof, tropisetron and/or analogues thereof, nimetazepam and/or analogues thereof, tropinol-esters and/or related esters and/or analogues thereof, TrkA kinase inhibitors (e.g., ADDN-1351) and/or analogues thereof, D2 receptor agonists, alpha1-adrenergic receptor antagonists, and APP-specific BACE inhibitors including, but not limited to galangin, a galangin prodrug, rutin, a rutin prodrug, and other flavonoids and flavonoid prodrugs, and a hydantoin (e.g., as described in WO 2014127042 (PCT/PCT/US14/016100) which is incorporated herein by reference for the hydantoins described therein.

Metadata:
- Claim Count in Document: 67.0
- Percentile: 93.0
- Lexical Diversity: 1.3
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15508059', '15798287', '13130525', '15321684', '11079116']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7336143653788708
- 35 USC 102 Novelty (BERT): 0.4852467273513598
- Combined Prediction Score: 0.7087776015761197
- Mean Citation Score: 175.84448999999995
- Max Citation Score: 196.03221
- Similarity Product: 140.15060445950388

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test